Aspirin update.
Wynn
Richard L
RL
Department of Oral Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, USA.
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005884:Gingival Hemorrhage / Q000139:chemically induced; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin